Dare Bioscience Inc (DARE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2023 | 03-2023 | 12-2022 | 09-2022 | 06-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -16,805 | -8,043 | -30,948 | -15,005 | -7,985 |
| Depreciation Amortization | 19 | 10 | 24 | 14 | 11 |
| Accounts receivable | N/A | N/A | N/A | N/A | -10,000 |
| Accounts payable and accrued liabilities | 4,513 | 668 | -75 | 1,374 | -989 |
| Other Working Capital | -7,375 | -8,799 | 10,700 | 1,190 | -13,898 |
| Other Operating Activity | -3,057 | 47 | 2,211 | 235 | 12,069 |
| Operating Cash Flow | $-22,704 | $-16,118 | $-18,088 | $-12,192 | $-20,792 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | N/A | -63 | -60 | -5 |
| Investing Cash Flow | $N/A | $N/A | $-63 | $-60 | $-5 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 1,752 | 1,299 | 1,343 | 1,343 | 1,339 |
| Financing Cash Flow | $1,752 | $1,299 | $1,343 | $1,343 | $1,339 |
| Exchange Rate Effect | -53 | -22 | -196 | -376 | -145 |
| Beginning Cash Position | 34,670 | 34,670 | 51,674 | 51,674 | 51,674 |
| End Cash Position | 13,664 | 19,829 | 34,670 | 40,390 | 32,071 |
| Net Cash Flow | $-21,006 | $-14,840 | $-17,005 | $-11,285 | $-19,604 |
| Free Cash Flow | |||||
| Operating Cash Flow | -22,704 | -16,118 | -18,088 | -12,192 | -20,792 |
| Capital Expenditure | N/A | N/A | -63 | -60 | -5 |
| Free Cash Flow | -22,704 | -16,118 | -18,152 | -12,252 | -20,797 |